The Cognitive Care Crisis Part 3: The Economic Gap

This is the third article in our series on The Cognitive Care Crisis.

In Part 1: The Diagnostic Gap, we explored how the healthcare system is failing to identify the root causes of cognitive decline. Too often, patients receive a diagnosis of mild cognitive impairment or Alzheimer’s disease without a meaningful investigation into the underlying drivers: metabolic dysfunction, inflammation, toxin exposure, sleep disruption, or vascular issues.

In Part 2: The Adherence Gap, we looked at the challenge of implementing the lifestyle and therapeutic changes required to reverse cognitive decline. Precision brain health requires sustained behavioral change: nutrition, sleep, exercise, detoxification, stress regulation, and social engagement and most patients need structured support to make that happen.

Today we look at the third and perhaps most consequential barrier:

The Economic Gap.

The Cost of the Brain Breaking Down

Cognitive decline is not just a medical problem. It is an economic one.

In the United States alone, the annual cost of Alzheimer’s disease and related dementias is estimated at over $350 billion, and that number is projected to exceed $1 trillion per year by 2050.

But that figure dramatically understates the true economic burden.

Because cognitive decline doesn’t just affect the patient.

It affects everyone around them.

There are three layers of cost:

1. Direct Medical Costs

These include:

• Neurology visits

• Brain imaging (MRI, PET scans)

• Prescription drugs

• Hospitalizations

• Long-term care facilities

Much of the current medical system is structured to pay for these services—even when they do little to change the trajectory of disease.

2. Long-Term Care Costs

Memory care is one of the most expensive forms of care in modern medicine.

Average annual costs in the U.S.:

• Assisted living with memory care: $70,000–$100,000+ per year

• Skilled nursing facilities: $100,000–$150,000+ per year

Many families exhaust lifetime savings trying to support a loved one with dementia.

For Medicare and Medicaid, these costs are enormous.

3. The Invisible Costs

The hidden costs may be the largest of all.

Every person with dementia often requires multiple caregivers.

If professional care isn’t affordable, family members step in.

That means:

• Spouses leaving the workforce

• Adult children reducing work hours

• Lost productivity across the economy

• Emotional and psychological strain on families

In the U.S., family caregivers provide an estimated $300+ billion in unpaid care each year.

And that number continues to grow. We are clearly all cognitively interdependent and this is what led our mastermind group to launch the “Cognitive Declaration of Interdependence”

The Broader Brain Economy

It’s not just Alzheimer’s.

Cognitive dysfunction shows up across a wide spectrum:

• Depression

• Anxiety

• Brain fog

• Chronic fatigue

• Burnout

• Neuroinflammation

• Early cognitive impairment

When you include the economic impact of mental health conditions, lost productivity, and disability, the total cost of brain-related disorders reaches trillions of dollars annually.

In many ways, the brain is the most expensive organ to have fail.

The Evolutionary Mismatch

What makes this crisis even more striking is that Alzheimer’s disease is not universal across human populations.

Anthropological research shows that in some traditional societies, particularly populations living close to ancestral lifestyles, rates of Alzheimer’s are extremely low. We recorded a podcast on this topic.

Researchers studying groups like the Tsimané in Bolivia have found some of the lowest dementia rates ever recorded.

Why?

Because many of the drivers of modern cognitive decline are products of evolutionary mismatch:

• Ultra-processed diets

• Chronic metabolic dysfunction

• Environmental toxins

• Sedentary lifestyles

• Social isolation

• Chronic stress

When the environment shifts away from what the human brain evolved to expect, disease emerges.

The Paradox of Modern Healthcare

Here is where the economic gap becomes clear.

Our healthcare system is willing to pay for:

• Brain scans

• Specialist visits

• Institutional care

• High-cost drugs like Lecanemab

But it typically does not pay for the interventions most likely to reverse cognitive decline:

• Comprehensive root-cause diagnostics

• Personalized nutrition programs

• Lifestyle medicine support

• Functional lab testing

• Supplements and targeted therapies

• Health coaching

• Dietitians

• Community-based support

The very interventions required to rebuild brain resilience are often out-of-pocket expenses.

The Precision Medicine Model

Precision medicine programs for cognitive decline look very different from conventional neurology.

They involve coordinated care teams, often including:

• A clinician to quarterback care

• A health coach for supporting implementation

• A dietitian for meal plans

• A pharmacist for polypharmacy

• Often behavioral or lifestyle support

This is the only care delivery system that has ever reversed cognitive decline consistently.

Instead of treating symptoms, these programs address multiple drivers simultaneously as well as building the psychosocial foundations for each patient.

This is the model used in the randomized controlled trial that successfully treated Alzheimer’s, where early results suggest that over 90% of participants improved or reversed cognitive decline using a precision medicine approach.

But these programs are not reimbursed. Elements of it are (some of the tests, doctor visits and dieticians can be sometimes covered under insurance or Medicare)

Which means access is limited.

And the system continues to pay for care after the brain fails rather than before it does.

The “When” of Care

For this type of care to be most cost effective, the earlier we can intervene the better. There are more and more tools to identify early stage or Alzheimer’s and Mild Cognitive Impairment. Imagine a root cause analysis screening for every 65 year old as they enter Medicare?

Or ideally an ongoing, longitudinal monitoring. That’s the vision for TruNeura.

Closing the Economic Gap

If we want to change the trajectory of cognitive decline, we must close the economic gap.

That means finding new ways to pay for precision brain health.

Several pathways are emerging:

Cash-Pay Programs

Today, most if not all patients access these services directly, paying out of pocket for comprehensive programs.

Direct-to-Employer Health Programs

Employers increasingly recognize that brain health affects productivity, burnout, and long-term disability costs.

Direct contracting models could allow companies to offer precision brain health as an employee benefit.

Value-Based Medicare Programs

Ultimately, the largest opportunity lies within Medicare and Medicare Advantage.

If coordinated precision medicine programs can demonstrate:

• reduced dementia progression

• fewer hospitalizations

• delayed institutional care

They could, theoretically, save the healthcare system hundreds of billions of dollars. I love this graphic.

The Opportunity Ahead

The cognitive care crisis is not just a medical challenge.

It is an economic one.

But it is also an opportunity.

For the first time, we have emerging evidence that cognitive decline can be reversed in many cases when we address the full network of root causes.

The question now is not whether this approach works.

The question is whether our economic systems are ready to support it.

Because if they are not, the cost of doing nothing will be far greater.

If you are interested in helping close the economic gap in cognitive care, whether as a practitioner, employer, or healthcare leader, you can learn more about the work we’re doing at TruNeura.

Or book a time to speak with our team.

The future of brain health will not be built by a single clinic or technology.

It will be built by a network of people committed to solving the cognitive care crisis together.